Organic Active Ingredients TRIZ Cases

Dimethylamine 4-O-acetyl inula lactone A derivative enhances oral bioavailability and chemical stability through targeted acetylation.

Selective pyrido diazepine compounds modulate GABA A gamma1 receptors to enhance neurotransmission while avoiding sedative side effects.

Trifluoro-substituted benzimidazoles deliver selective CB2 agonism to treat chronic pain while minimizing central adverse events.

Solid oral vinorelbine ditartrate formulations use specific excipients to maintain bioavailability and patient comfort.

Biodegradable contraceptive implants use polyester copolymers to provide sustained levonorgestrel release.

ROCK inhibitors decrease phosphorylated tau protein ratios and amyloid-beta levels, addressing underlying neurophysiological changes in Alzheimer's disease.

Thieno[3,2-d]pyrimidine derivatives resolve selectivity versus safety contradictions by activating TLR7 and TLR8 with improved potency.

Novel substituted tetrahydroisoquinoline compounds act as selective inhibitors of serine protease enzymes.

Dispersing vitamin B12 particles in a hydrophobic carrier improves bioavailability and reduces intense red color for safe intranasal administration.

Thioester cationic lipids improve transfection efficiency while reducing toxicity through optimized headgroup composition.

Formula I compounds inhibit the URAT1 transporter to lower blood uric acid concentration, avoiding hepatotoxicity and severe dermatological reactions.

Synthetic anellosomes encapsulate genetic material within proteinaceous exteriors to deliver therapeutic agents while minimizing unwanted immune responses.

Segmented oxadiazole structures achieve selective alpha4beta2 receptor modulation, resolving safety and efficacy trade-offs in CNS disorder treatments.

Binary hyaluronic acid mixture combines low and high molecular weight fractions to form a protective scaffold on tissue surfaces.

Oral gut-selective JAK3 inhibitor dosing minimizes systemic immunosuppression to reduce adverse effects while treating inflammatory diseases.

Tripartite androgen receptor eliminators merge antagonists with elimination promoters to clear receptors, treating hair loss and acne without safety trade-offs.

A composition combining microalgal DHA with plant-derived phospholipids to enhance fatty acid absorption.

Ceramide conjugation directs intracellular trafficking to prolong drug half-life while reducing systemic toxicities from parenteral administration.

Combining amino acids and vitamins in a single formulation addresses high costs and limited efficacy of existing nerve restoration drugs.

A trolox-peptide conjugate inhibits neurotransmitter release to relax muscles and improve skin conditions.

Masked polyamines shield membrane activity during circulation, then disrupt endosomal membranes at acidic pH to release nucleic acids into the cytoplasm.

X4P-001 blocks the CXCL12/CXCR4 axis to enhance CD8+ T cell density, reducing metastasis while minimizing toxicity in renal cell carcinoma treatment.

Chlorin e4 analogues enhance photodynamic activity and fluorescence while minimizing dark toxicity through structural optimization.

8beta-substituted estrogens activate estrogen receptor beta to treat infertility without causing endometrial hyperplasia.

Cannabinoid-phospholipid conjugates use a maleic acid linker to covalently attach cannabinoids to phospholipids for targeted delivery.

Covalently coupling agmatine to dextran via periodate activation creates a composite material that kills tumor cells while minimizing toxic side effects.

Ovothiol compounds extracted from sea urchin eggs inhibit inflammatory cytokine pathways to reduce chronic low-grade systemic inflammation.

Biomarker panels predict mesalamine response to reduce treatment failures and costs by tailoring therapy.

25-hydroxycholesterol inhibits crystallin alpha B protein aggregation to selectively eliminate senescent cells.

Colloid formulation of (S)-3-[1-methylpyrrolidin-2-yl]pyridine bypasses gastrointestinal absorption to achieve rapid onset and high bioavailability.

A peptide hydrogel composite encapsulates nucleic acid nanoparticles to enable localized delivery and cellular uptake.

A syringe body with a Luer-Lock connector minimizes Needle Pop Off resistance for viscous media injection.

Segmented peptide molecules self-assemble into monodisperse capsomers, resolving polydispersity in nucleic acid delivery systems.

A kit of parts mixes amino acids with an active halogen compound to form a treatment preparation.

An indoloquinazolidine alkaloid suppresses HSP70 protein expression and inhibits tumor growth in cancer models.

Nano-silica coating on excipient cores reduces interparticle cohesion to resolve the trade-off between tablet strength and powder flowability.

Substituted 6-aza-isoindolin-1-one derivatives inhibit spleen tyrosine kinase activity for treating immune disorders.

Segmented housing walls manage osmotic pressure to minimize urine pH impact on erdafitinib release rates for bladder cancer treatment.

Pyridazine derivatives bind pre-mRNA to modulate nucleic acid splicing, resolving limited regulation of alternative splicing patterns.

A specific polypeptide sequence reduces adhesion formation while preserving bowel integrity.

Sulfur combined with aloe vera pulp reduces odor while enhancing antimicrobial activity for faster animal wound healing.

Edible oil carriers dissolve hydrophobic neurosteroids, resolving poor aqueous solubility and enabling effective oral delivery.

A solvent tank and hopper system extracts medicinal compounds using supercritical carbon dioxide to store diluted cannabinoids.

Polymer terbinafine nanoparticles enhance tissue penetration and reduce systemic toxicity.

Solid-phase extraction and preparative liquid chromatography isolate myricetin-3-O-(2″-O-galloyl)-α-L-rhamnoside and myricetin-3-O-(4″-O-galloyl)-α-L-rhamnoside.

Selective androgen receptor modulators bind androgen receptors to induce apoptosis in AR-positive breast cancer cells resistant to standard hormone therapies.

Targeting VCAM-1/α4β1 signaling reduces tumor burden despite complex genetic alterations in osteosarcoma.